Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Expression profiles of SnoN in normal and cancerous human tissues support its tumor suppressor role in human cancer.

Jahchan NS, Ouyang G, Luo K.

PLoS One. 2013;8(2):e55794. doi: 10.1371/journal.pone.0055794. Epub 2013 Feb 13.

2.

Dual role of SnoN in mammalian tumorigenesis.

Zhu Q, Krakowski AR, Dunham EE, Wang L, Bandyopadhyay A, Berdeaux R, Martin GS, Sun L, Luo K.

Mol Cell Biol. 2007 Jan;27(1):324-39. Epub 2006 Oct 30.

3.

SnoN in mammalian development, function and diseases.

Jahchan NS, Luo K.

Curr Opin Pharmacol. 2010 Dec;10(6):670-5. doi: 10.1016/j.coph.2010.08.006. Epub 2010 Sep 6. Review.

4.

SnoN/SKIL modulates proliferation through control of hsa-miR-720 transcription in esophageal cancer cells.

Shinozuka E, Miyashita M, Mizuguchi Y, Akagi I, Kikuchi K, Makino H, Matsutani T, Hagiwara N, Nomura T, Uchida E, Takizawa T.

Biochem Biophys Res Commun. 2013 Jan 4;430(1):101-6. doi: 10.1016/j.bbrc.2012.11.005. Epub 2012 Nov 12.

PMID:
23154181
5.

Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma.

Fukuchi M, Nakajima M, Fukai Y, Miyazaki T, Masuda N, Sohda M, Manda R, Tsukada K, Kato H, Kuwano H.

Int J Cancer. 2004 Mar 1;108(6):818-24.

6.

Oncogene and tumour suppressor: the two faces of SnoN.

Lamouille S, Derynck R.

EMBO J. 2009 Nov 18;28(22):3459-60. doi: 10.1038/emboj.2009.311.

7.
8.

SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma.

Akagi I, Miyashita M, Makino H, Nomura T, Hagiwara N, Takahashi K, Cho K, Mishima T, Takizawa T, Tajiri T.

Ann Surg Oncol. 2008 Oct;15(10):2965-75. doi: 10.1245/s10434-008-9986-y. Epub 2008 Jul 9.

PMID:
18612694
10.

The influence of SnoN gene silencing by siRNA on the cell proliferation and apoptosis of human pancreatic cancer cells.

Liu C, Zhang H, Zang X, Wang C, Kong Y, Zhang H.

Diagn Pathol. 2015 Apr 18;10:30. doi: 10.1186/s13000-015-0267-3.

11.

Ski/SnoN expression in the sequence metaplasia-dysplasia-adenocarcinoma of Barrett's esophagus.

Villanacci V, Bellone G, Battaglia E, Rossi E, Carbone A, Prati A, Verna C, Niola P, Morelli A, Grassini M, Bassotti G.

Hum Pathol. 2008 Mar;39(3):403-9. doi: 10.1016/j.humpath.2007.07.009.

PMID:
18261624
12.
13.

Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins.

Krakowski AR, Laboureau J, Mauviel A, Bissell MJ, Luo K.

Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12437-42. Epub 2005 Aug 18.

14.

TGF-beta repressors SnoN and Ski are implicated in human colorectal carcinogenesis.

Bravou V, Antonacopoulou A, Papadaki H, Floratou K, Stavropoulos M, Episkopou V, Petropoulou C, Kalofonos H.

Cell Oncol. 2009;31(1):41-51.

15.

Ski-related novel protein N (SnoN), a negative controller of transforming growth factor-beta signaling, is a prognostic marker in estrogen receptor-positive breast carcinomas.

Zhang F, Lundin M, Ristimäki A, Heikkilä P, Lundin J, Isola J, Joensuu H, Laiho M.

Cancer Res. 2003 Aug 15;63(16):5005-10.

16.

Overexpression of SnoN/SkiL, amplified at the 3q26.2 locus, in ovarian cancers: a role in ovarian pathogenesis.

Nanjundan M, Cheng KW, Zhang F, Lahad J, Kuo WL, Schmandt R, Smith-McCune K, Fishman D, Gray JW, Mills GB.

Mol Oncol. 2008 Aug;2(2):164-81. doi: 10.1016/j.molonc.2008.05.001. Epub 2008 May 10.

17.

SnoN: bridging neurobiology and cancer biology.

Pot I, Ikeuchi Y, Bonni A, Bonni S.

Curr Mol Med. 2010 Oct;10(7):667-73.

18.

SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.

Band AM, Laiho M.

Cell Signal. 2012 Apr;24(4):922-30. doi: 10.1016/j.cellsig.2011.12.015. Epub 2011 Dec 29.

19.

Phospholipid Scramblase 1, an interferon-regulated gene located at 3q23, is regulated by SnoN/SkiL in ovarian cancer cells.

Kodigepalli KM, Anur P, Spellman P, Sims PJ, Nanjundan M.

Mol Cancer. 2013 Apr 26;12:32. doi: 10.1186/1476-4598-12-32.

20.

Transforming growth factor-β/SMAD Target gene SKIL is negatively regulated by the transcriptional cofactor complex SNON-SMAD4.

Tecalco-Cruz AC, Sosa-Garrocho M, Vázquez-Victorio G, Ortiz-García L, Domínguez-Hüttinger E, Macías-Silva M.

J Biol Chem. 2012 Aug 3;287(32):26764-76. doi: 10.1074/jbc.M112.386599. Epub 2012 Jun 6.

Supplemental Content

Support Center